Somatropin Injection Shortage

• • Genotropin MiniQuick injection, Pfizer, 0.4 mg, cartridge, 7 count, NDC 00013-2650-02
  • Norditropin Flexpro subcutaneous solution for injection, Novo Nordisk, 10 mg/1.5 mL, pen injector, 1 count, NDC 00169-7705-21
  • Norditropin Flexpro subcutaneous solution for injection, Novo Nordisk, 15 mg/1.5 mL, pen injector, 1 count, NDC 00169-7708-21
  • Norditropin Flexpro subcutaneous solution for injection, Novo Nordisk, 30 mg/3 mL, pen injector, 1 count, NDC 00169-7703-21
  • Norditropin Flexpro subcutaneous solution for injection, Novo Nordisk, 5 mg/1.5 mL, pen injector, 1 count, NDC 00169-7704-21

• • Novo Nordisk has Norditropin on shortage due to increased demand and manufacturing delays.
  • Pfizer has Genotropin on shortage due to increased demand.

• • Genotropin injection, Pfizer, 12 mg, cartridge, 1 count, NDC 00013-2646-81
  • Genotropin injection, Pfizer, 5 mg, cartridge, 1 count, NDC 00013-2626-81
  • Genotropin MiniQuick injection, Pfizer, 0.2 mg, cartridge, 7 count, NDC 00013-2649-02
  • Genotropin MiniQuick injection, Pfizer, 0.6 mg, cartridge, 7 count, NDC 00013-2651-02
  • Genotropin MiniQuick injection, Pfizer, 0.8 mg, cartridge, 7 count, NDC 00013-2652-02
  • Genotropin MiniQuick injection, Pfizer, 1 mg, cartridge, 7 count, NDC 00013-2653-02
  • Genotropin MiniQuick injection, Pfizer, 1.2 mg, cartridge, 7 count, NDC 00013-2654-02
  • Genotropin MiniQuick injection, Pfizer, 1.4 mg, cartridge, 7 count, NDC 00013-2655-02
  • Genotropin MiniQuick injection, Pfizer, 1.6 mg, cartridge, 7 count, NDC 00013-2656-02
  • Genotropin MiniQuick injection, Pfizer, 1.8 mg, cartridge, 7 count, NDC 00013-2657-02
  • Genotropin MiniQuick injection, Pfizer, 2 mg, cartridge, 7 count, NDC 00013-2658-02

Estimated Resupply Dates

• • Novo Nordisk has Norditropin FlexPro prefilled pens on intermittent back order and the company is releasing supplies as they become available.
  • Pfizer has Genotropin MQ 0.4 mg cartridges on back order and the company estimates a release date of June 2024.

Implications for Patient Care

• • 1

Safety

• • 1.

Alternative Agents & Management

• • 1.